A decades-old cough medicine, Ambroxol, could be on the verge of a dramatic second act—not for sore throats, but for protecting the brain. In a year-long clinical trial, researchers gave Ambroxol to people with Parkinson’s-related dementia and found that it reached the brain, slowed signs of cell damage, and helped stabilize memory and psychiatric symptoms. […]



Summary

Ambroxol, a long-used cough medicine, shows promise in treating Parkinson’s-related dementia. A year-long trial demonstrated its ability to reach the brain, slowing cell damage markers and stabilizing memory and psychiatric symptoms in participants. This suggests Ambroxol may offer a novel approach to combat neurodegenerative diseases by targeting the brain directly, repurposing a familiar drug for a significant new application. Further research is needed to confirm these findings and explore its potential benefits for other neurological conditions.

Read more…

This post is part of “Science and Technology News”, Follow for more…!!!

Credits: Source

Disclaimer